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Abstract 
Purpose: To evaluate the effect of surfactants on plasmid DNA during preparation and release from 
polylactic glycolide (PLGA) microspheres. 
Methods: Various surfactants, both ionic and non-ionic (Span, Tween, Triton X100, 
cetyltrimethylammonium bromide and sodium dodecyl sulphate), were added during the microsphere 
preparation and their effect was evaluated. Supercoil index (SCI) was introduced as a harmonised value 
derived from encapsulation efficiency and supercoil preservation efficiency in order to evaluate the 
impact of different surfactants on pDNA encapsulation.  
Results: Polyvinyl alcohol and Span revealed low SCI whereas Tween increased the SCI in a fraction-
dependent manner. The Tween blend of hydrophilic-lipophilic balance (HLB) of 16 and Triton X-100 
(HLB = 13.5) showed the highest SCI. Span revealed high burst release of pDNA whereas Triton X-100 
exhibited low burst release. Following the burst release, diffusion mechanism was found to predominate 
in DNA release.  
Conclusion: The microspheres were non-toxic to the neuro-2a cells which suggest they can be 
potentially used in the gene therapy of neuronal diseases. 
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INTRODUCTION 
 
Gene therapy remains attractive as a promising 
treatment approach for a wide range of diseases 
like cancer and allergies. A successful gene 
delivery system should be able to deliver nucleic 
acid efficiently to the target cell or tissue. Cell 
uptake of the gene delivery system and the 
release of the encapsulated nucleic acid are 
strongly related to the carrier physicochemical 
properties, which eventually will affect the 
transfection efficiency [1].  
 
Solvent-evaporation method is a versatile 
technique to encapsulate macromolecules like 
DNA. The technique requires surfactant as the 
main component in the fabrication. A number of 
studies employing the technique have shown that 
surfactants had effects on the particle physical 
aging [2], internal structure [3] and morphological 
characteristics, [4].  
 
However, to the best of our knowledge, there are 
no studies on the influence of surfactant on 
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preservation of plasmid DNA (pDNA) integrity. It 
is a known fact that the super coil (SC) isoform of 
pDNA exerts the highest transfection efficiency 
[5]. High shear during microsphere fabrication by 
solvent-evaporation easily exposes pDNA to 
degradation detrimental to the efficacy of the 
gene delivery system. Reported attempts to 
preserve the pDNA integrity included freezing of 
the primary emulsion [6] and condensing the 
pDNA with cationic excipients [7,8]. Other 
excipients that have been also used to improve 
pDNA stability are lactose [6] and buffering 
agents such as NaHCO3 and Na2HPO4 [9].  
 
In this study we encapsulated pDNA in Poly(D,L-
lactide-co-glycolide) (PLGA) microspheres with 
the focus on the role of surfactants in preserving 
the SC integrity of pDNA and attenuating the 
release properties.  
 
EXPERIMENTAL  
 
Materials 
 
Plasmid DNA (pGL3-control vector) was 
purchased from Promega, Madison, WI. 
PLGA5004 (IV 0.4 dl/g, ester-capped, of lactic to 
glycolic acid ratio of 50:50) was purchased from 
Purac, Gorinchem, Netherland. Polyvinyl alcohol 
(PVA) was purchased from BDH Chemicals, 
Poole, England. Cetyltrimethylammonium 
bromide (CTAB) and dichloromethane (DCM) 
were purchased from Sigma-Aldrich, Steinheim, 
Germany. Tween 20, Tween 80, Span 80, Span 
85, Triton X100 (TX) and sodium dodecyl 
sulphate (SDS) were purchased from Merck, 
Hohen-brunn, Germany.  
 
Preparation and isoform analysis of pDNA 
 
Plasmid DNA was amplified in E. coli (Max 
Efficiency Dh5α, Invitrogen) and extracted using 
PureYield™ Plasmid Maxiprep System 
(Promega, Madison, WI) according to the 
manufacturer’s protocol. The concentration and 
purity of pDNA were determined by measuring 
the absorbance at 260 nm (A260) and the ratio 
A260/A280, respectively.  
 
Following the extraction and purification steps, 
the pDNA was subjected to isoform analysis.  
Briefly, the purified pDNA together with 1 kb DNA 
ladder  (GeneRuler™ 1 kb DNA Ladder, 
Fermentas) were  loaded to 1 % w/v agarose gel 
in 1X Tris-acetate-EDTA (TAE) buffer and run at 
5 V/cm for 90 min. The agarose was then stained 
with 0.5 µg/mL ethidium bromide and the image 
was captured by Gel Documentation System 
(Vilber Lourmat, France). The different isoforms 
of the plasmid migrated at different speeds in the 
gel resulting in separated bands after staining. 
The bands were further analysed using ImageJ 
software version 1.43u (US National Institute of 
Health) in order to integrate the optical density of 
each band. SC preservation of each lane is the 
optical density corresponding to the SC relative 
to the total optical density of all bands in the lane, 
expressed as percentage.  
 
Preparation of pseudo-primary emulsion  
   
Pseudo-primary emulsions were prepared to 
have similar ratio between components (water, 
DCM and surfactants) used in the microsphere 
fabrication. The word “pseudo” implied that 
PLGA and pDNA were not added to the oil and 
aqueous phases, respectively. 1 % w/v (relative 
to the total volume of the emulsion) of the 
surfactants was added to a mixture of 
water:DCM  (1:10) then the mixture was 
homogenised for 1 min. Emulsion stability was 
evaluated by naked eyes wherein the time taken 
for the two phases to separate was recorded.  
  
Fabrication of pDNA-loaded PLGA 
microspheres  
  
Microparticles were prepared by a modified 
water-in-oil-in-water (W1/O/W2) double emulsion 
solvent-evaporation method as described before 
[10]. Briefly, pDNA in Tris-EDTA (TE) buffer 
(composing W1 phase) was added to the oil 
phase (O) composed of PLGA 5004 in DCM then 
homogenised at 14,500 rpm for 1 min using 
IKA® T10 basic homogeniser (IKA Werke GmbH 
and Co., Staufen, KG, Germany). The resultant 
primary emulsion (W1/O) was immediately 
injected into 1 % w/v PVA (W2) and 
homogenised for 3 min at the same speed to 
produce the secondary emulsion (W1/O/W2). 
The latter emulsion was immediately injected into 
a continuously stirred hardening tank constituted 
of 1 % w/v PVA. Stirring was continued for 2 h to 
allow complete evaporation of the DCM. The 
hardened microspheres were then collected by 
centrifugation, washed three times with deionised 
water then lyophilised. Surfactants were added 
as 1 % w/v of the primary emulsion. Span and 
Tween surfactants were blended together to 
generate a scale of HLB from 4.0 to 16.0.  TX 
was used either alone (HLB=13.5) or mixed with 
Span to yield HLB 10.0. SDS (HLB = 40) and 
CTAB (HLB = 10) were individually used (Table 
1). 
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Table 1: Blends of surfactants used in emulsion 
stability and microsphere formulation 
 
No. Surfactant(s) HLB  
F1 PVA  - 
F2 88% Span 80, 12% Span 85 4.0 
F3 75% Span 80, 25% Tween 80 7.0 
F4 46% Span 80, 54% Tween 80 10.0 
F5 14% Span 80, 86% Tween 80 13.5 
F6 41% Tween 80, 59% Tween 20 16.0 
F7 TX 13.5 
F8 SDS 40.0 
F9 CTAB 10.0 
F10 38% Span 80, 62% TX 10.0 
 
Characterisation of pDNA-loaded PLGA 
microspheres  
 
Particle size 
 
Particle size was measured prior to lyophilisation 
by laser diffraction sizing analyser (BT-9300H 
Dandong Bettersize Instruments, Dandong, 
China) and expressed as volume median 
diameter (D 0.5).  
 
Encapsulation and supercoil preservation 
efficiency 
 
An amount of 5-10 mg of lyophilised 
microspheres was solubilised in chloroform and 
pDNA was extracted into TE buffer as described 
by Mohamed and van der Walle [4]. The 
aqueous layer was subjected to UV absorbance 
at 260 nm to determine pDNA concentration and 
encapsulation efficiency, and agarose gel 
electrophoresis for post-fabrication isoform 
analysis of pDNA.  
  
Supercoil index (SCI) 
 
SCI is proposed as a primary indicator of the 
quality of the pDNA-loaded microspheres. SCI is 
harmonised value from encapsulation efficiency 
and supercoil preservation efficiency, calculated 
by the following equation: 
 
SCI = ESp/100 ……………………………… (1) 
 
where E and Sp are encapsulation efficiency and 
supercoil preservation efficiency, respectively 
 
SCI value indicates the amount of SC pDNA 
being encapsulated in the microspheres, making 
it more suitable to compare different microsphere 
formulations. As SCI is merely a calculated 
value, it was used only to compare different 
microsphere formulations. However, the effect of 
different variables was discussed separately for 
each of encapsulation efficiency and supercoil 
preservation efficiency. 
Thermal analysis 
 
Differential scanning calorimetry was conducted 
by a Differential Scanning Calorimeter (DSC1, 
STARe System, Mettler Toledo) using 2-3 mg of 
each sample in a standard 40 µL aluminium 
crucible with pin-hole [11]. Both sample and 
reference (empty crucible with pin-hole) were left 
to equilibrate at 0 °C for 5 min (isothermal 
segment), heated to 85 °C (first heating), 
quench-cooled to -20 °C then re-heated again to 
85°C (second heating). The first heating was 
conducted to eliminate the thermal history of the 
sample. 
 
Surface morphology 
 
Microspheres were sprinkled onto aluminium 
stub, pre-pasted with carbon adhesive tape. 
Samples were sputter-coated with gold and then 
viewed using Carl Zeiss Evo® 50 scanning 
electron microscope (SEM) (Oberkochen, 
Germany). 
 
Fluorescence microscopy 
 
Ethidium bromide was added to the pDNA 
solution prior to microsphere fabrication. 
Ethidium bromide binds to the double-strand 
pDNA producing fluorescence that can be 
detected under the fluorescence microscope. 
After fabrication, microspheres were suspended 
in deionised water in a 24-well plate and viewed 
under a Nikon Eclipse Ti fluorescence 
microscope. 
 
In vitro release studies 
 
Selected formulations were subjected to in vitro 
release study over a period of 4 weeks. Ten 
milligram of each formulation was suspended in 
800 µL TE buffer containing 0.02 % w/v sodium 
azide and left undisturbed in a 37 °C incubator. 
At a predetermined time intervals (90 min, 5 h, 1 
day, 3 days and 1, 2, 3 and 4 weeks), the 
microspheres were centrifuged and 600 µL of the 
supernatant was withdrawn and replenished with 
equal volume of fresh TE buffer.  
 
Concentration of pDNA was estimated by 
measuring the absorbance at 260 nm using UV 
spectrophotometer (Hitachi U1900 
spectrophotometer, Japan). To study the stability 
of pDNA during the release period, 10 mg of 
each of microsphere formulations was 
suspended in 800 µL TE buffer then analysed by 
agarose gel after 90 min, 1 day, 1 week and 4 
weeks. 
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Determination of cytotoxicity of microspheres 
 
Neuro 2a (N2a) cells were seeded in 96-well flat-
bottom microplate at a density of 2.5 x 105 cells 
per well and allowed to resume the growth by 
incubating the plate for 48 h at 37 ºC and 5 % 
CO2. The cells were treated with different 
microsphere formulations at different 
concentrations (1, 10, 50, 100 and 500 µg/mL). 
After 48 h, the media were discarded and 
substituted with 30 µL of [3-(4, 5-
dimethylthiazole-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulphonul)-2H-
tetrazolium] (MTT) reagent. The plate was then 
incubated for 4 h. Following the incubation, 120 
µL of DMSO was added and the absorbance of 
each well was read at 570 nm using Tecan 
Infinite 200 micro plate reader (Tecan Austria 
GmbH, Grödig, Austria). The results were 
expressed as percentage relative to the control 
(untreated cells) which was assumed as 100 % 
viable. 
 
Statistical analysis 
 
All data were obtained in triplicate and reported 
as mean ± standard deviation (SD). One-way 
ANOVA with 95 % confidence interval (p < 0.05) 
followed by Tukey post-hoc test was applied 
using Minitab (ver. 16) software (Minitab, 
Philadelphia, PA). 
 
RESULTS 
 
Pseudo-primary emulsion stability 
 
As shown in Fig 1, stability of the emulsion 
increased as a function of HLB value for all 
sorbitan-based surfactants. TX with similar HLB 
(13.5) to that of Span-Tween blend gave lower 
stability, but the stability was comparable to 1 % 
w/v PVA. The latter has been commonly used in 
microencapsulation. In contrast, the cationic 
surfactant CTAB resulted in similar stability to 
that of sorbitan-based surfactant blend of similar 
HLB while SDS seems to be a poor stabiliser. 
 
Effect of surfactants on pDNA-loaded PLGA 
microspheres  
 
Microsphere particle size 
 
Based on the results shown in Table 2, it 
appears that all Span-containing microspheres 
tend to be larger in size than microspheres 
prepared by other surfactants. The size of the 
microspheres increased when Span fraction 
increased. Furthermore, adding Tween to the 
Span produced larger or similar microspheres 
size (F3 - F5). However, when Tween was used 
alone it produced microspheres with significantly 
smaller size (F6).  
 
 
 
Figure 1: Screening of pseudo-primary emulsion stability 
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Similarly, PVA which is a polymeric stabiliser 
produced smaller microspheres. Likewise, Triton 
X-100 yielded comparable size to that of Tween 
and PVA despite its poor performance as 
stabiliser for the primary emulsion. CTAB (F9) 
yielded the smallest particle size while SDS 
produced significantly larger microspheres than 
CTAB. 
 
Microsphere encapsulation efficiency 
 
F6 formulation yielded the highest encapsulation 
efficiency and the most stable pseudo-primary 
emulsion (Table 2). The presence of hydrophobic 
Span surfactants in the formulation was 
deleterious to the encapsulation efficiency, as 
seen in F2-F5. This observation agrees with the 
results obtained by Mohamed and van der Walle 
[4] where it was shown that Tween 20 revealed 
higher pDNA encapsulation efficiency than Span 
80. Although TX (HLB 13.5, F7) was a poor 
stabiliser of the pseudo-primary emulsion, it 
yielded similar encapsulation efficiency to that of 
Span-Tween microspheres (F3-F5).  Similarly, 
when TX was blended with Span (F10), the 
encapsulation efficiency was compared to TX 
alone despite of the higher stability of the 
pseudo-primary emulsion. Interestingly, CTAB 
yielded similar encapsulation efficiency to that of 
Tweens (F6) although CTAB was poor stabiliser 
of pseudo-primary emulsion. In contrast, SDS 
was a poor stabiliser of the pseudo-primary 
emulsion and cannot complex the pDNA leading 
to low encapsulation efficiency.  
 
Plasmid stability (SC preservation) and glass 
transition (Tg) 
 
Degradation of pDNA from SC to other isoforms, 
mainly open circular (OC) occurred in all 
formulations with exception of F9 where SC 
preservation was not possible to be measured 
(Table 2; Fig 2). PVA seems to have a good 
stabilising effect on pDNA despite its low 
encapsulation efficiency. For F2-F6 which 
consisted of Span-Tween blends, it was found 
that the SC preservation was improved as HLB 
value increased i.e. as Tween fraction increased. 
Similar trend was also observed in the 
encapsulation efficiency. This could be attributed 
to the fact that SC isoform which has smaller size 
is more difficult to integrate with the polymer 
molecules. Consequently, SC pDNA can easily 
escape to the outer W2 phase during the 
fabrication process. 
 
Table 2: Effect of different surfactants and surfactant blends on physical characteristics of pDNA-loaded PLGA 
microspheres. In each column, means that do not share a letter are significantly different (p<0.05).  
 
No. Particle size  
(µm) 
Encapsulation 
efficiency (%) 
Supercoil 
preservation (%) 
SCI Tg (°C) 
F1 10.4±0.02 (g) 27.7±7.4 (c, d) 71.7±10.1 (a, b) 20.3±7.4 (c, d) 42.4 
F2 18.3±0.07 (c) 13.9±5.3 (d) 23.9±0.4 (d) 3.3±1.2 (e) 40.5 
F3 27.8±0.08 (b) 50.8±1.0 (a, b, c) 21.8±0.8 (d) 11.1±0.5 (d, e) 40.6 
F4 17.7±0.24 (d) 55.7±9.1 (a, b, c) 45.9±0.7 (c) 25.5±3.8 (b, c, d) 41.1 
F5 17.0±0.10 (e) 68.6±7.9 (a, b) 48.5±0.6 (b, c) 33.2±3.6 (b, c) 41.2 
F6 10.2±0.20 (g) 75.9±5.3 (a) 67.5±7.9 (a, b) 51.4±8.4 (a) 40.1 
F7 12.8± 0.03 (f) 46.8±3.0 (b, c) 76.5±10.0 (a) 36. 0±7.0 (b) 40.9 
F8 9.2±0.02 (h) 11.3±1.7 (d) 31.8±10.8 (c, d) 3.6±1.4 (e) 43.3 
F9 2.2±0.0 (i) 72.6±21.4 (a, b) - - 42.4 
F10 29.9±0.49 (a) 47.4±14.7 (b, c) 82.7±9.4 (a) 38.3±7.0 (a, b) 38.5 
 
 
 
Figure 2: Agarose gel electrophoresis for the pDNA extracted from pDNA-loaded PLGA microspheres 
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TX exhibited the highest preservation efficiency 
(~ 77%). Blending TX with Span significantly 
improved the preservation efficiency (F10 vs. 
F2). In other words, presence of Span in TX did 
not reduce the effect of TX on pDNA integrity 
unlike the combination between Span and Tween 
which reduced the preserving effect of the 
Tween. Additionally, Span-TX of HLB 10 (F10) 
revealed higher pDNA stability than Span-Tween 
of the same HLB value (F4). SDS appeared to 
confer some protective effect on pDNA but this 
was of little significant due to the low 
encapsulation efficiency. It was not possible to 
assess the preservation efficiency of CTAB (F9) 
because there was no corresponding band 
detected on the agarose gel.   
 
Supercoil index (SCI) 
 
Encapsulation efficiency represents the ability of 
a specific formulation to encapsulate pDNA 
regardless of its isoform whereas SC 
preservation efficiency represents the ability of 
the formulation to preserve the encapsulated 
plasmid in its SC isoform. While it is important to 
characterise the formulations for both 
encapsulation and SC preservation efficiency, 
individual value does not reflect the overall 
quality of specific formulation. Hence, to 
harmonise the two values, the so-called 
Supercoil Index (SCI) was introduced as a 
valuable initial indicator of a good gene delivery 
system. Based on SCI, it is clearly seen that F6 
has the highest SCI, which indicates that Tween 
blend of HLB 16 could be used as a good gene 
delivery system.  
 
pDNA release profile 
 
Three formulations of different HLB values were 
selected for the release profile study. The low 
HLB (HLB 4 and HLB 7) formulations were not 
selected as they had low SCI and hence they are 
not good candidates as gene delivery carriers. 
For HLB 10 formulations (F4, F9 and F10) we 
selected F4 due its lower particle size. For HLB 
13.5 (F7 and F10) we selected F7 due to its 
lower particle size and higher SC preservation. 
F6 was the only formulation of HLB 16 with good 
SCI and hence it was selected. SDS formulation 
(HLB 40, F8) was not selected because of the 
low SCI. The cumulative release at pre-
determined time from the three selected 
formulations is shown in Fig 3 while Fig. 4 shows 
the SEM images of the microspheres taken prior 
to incubation in dissolution media (day 0) and 
following 24 h and 28 days of incubation. The 
three formulations had smooth surface without 
visible pores as represented by Fig. 4 on Day 0. 
All microspheres exhibited varying amount of 
burst release in the first 5 h, followed by 
sustained release phase over the 4 weeks. As 
repeatedly reported, the burst release was 
suggested to be due to the pDNA located near 
the surface [12]. Only F4 (Span-Tween blend of 
HLB 10) released more than 90 % over the 4 
weeks with more than 50 % burst release in the 
first 5 h. 
 
 
 
Figure 3: (A) Release profile of pDNA from pDNA-loaded PLGA microspheres. (B) Fitting the release profile 
kinetics on Higuchi model after excluding the burst release (24 h). 
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Figure 4: SEM images of pDNA-loaded PLGA microspheres before the release profile study (Day 0) and 
following Day 1 and Day 28 of the release. Arrow (A) denotes fractured microspheres 
 
Fig 5 shows the stability of pDNA during the 
release study using agarose gel electrophoresis 
to detect the presence of pDNA and its 
conformation. Only the pDNA from F4 was 
detected on agarose gel in the first week (Fig. 6) 
while the released pDNA from F6 and F7 was not 
detected. However, after 4 weeks the pDNA was 
detected from F4 and F6 but not F7. The pDNA 
released after 4 weeks exhibited bands close to 
the position of the SC bands of the original 
pDNA. The bands after 4 weeks appeared broad, 
which can be related to the acidic environment 
and the high osmolarity of the release medium 
due to PLGA degradation. The pH of the release 
medium was tested using Merck pH strips after 1 
and 4 weeks and revealed that the media were 
acidic in the three formulations. After 1-week, 
media pH was 5-6 while after 4-weeks media pH 
was 4-5. 
 
Cytotoxicity of microspheres 
 
The microsphere formulations did not show 
significant cytotoxicity on N2a cells even at high 
concentration of 500 µg/mL (Fig 6). 
 
 
 
 
Figure 5: Stability of pDNA released from the microspheres as revealed by agarose gel electrophoresis. Lanes: 
(1) ladder, (2) pDNA used in the microsphere fabrication, (3) pDNA released from F4, (4) pDNA released from 
F6, (5) pDNA released from F7, (6) pDNA extracted from F7 after 4-week release 
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Figure 6: Cytotoxicity of the microspheres on N2a cells 
 
DISCUSSION 
 
Primary emulsion stability and polymer 
precipitation conditions play important roles in 
the encapsulation efficiency and the internal 
structure of the particles [13]. The notably small 
particle size of CTAB-PLGA microspheres may 
be attributed to the solubility of CTAB in both oil 
and aqueous phases as well as the electrostatic 
repulsion as observed in other studies [11,14]. In 
addition, the positively charged CTAB can 
interact with the negatively charged pDNA 
resulting in condensed structure that aids in 
producing smaller particles. The overall results 
suggest that the HLB and stability on the primary 
emulsion are not indicative of the microspheres 
size wherein surfactants of same HLB value 
resulted in microspheres with different size (F5 
vs. F7, F4 vs. F9 & F10). However, the stability 
of pseudo-primary emulsion was correlated to 
the encapsulation efficiency where F6 
formulation yielded the highest encapsulation 
efficiency and the most stable pseudo-primary 
emulsion. The presence of hydrophobic Span 
surfactants in the formulation was deleterious to 
the encapsulation efficiency, as seen in F2-F5. 
This is because Span surfactants stabilise W/O 
emulsions and potentially induce the formation of 
reverse micelles. These reversed micelles 
transport the water and the water soluble pDNA 
from the internal W1 to the external W2 phase 
through the thin layer of the oil phase [15]. 
 
It is believed that the SC isoform has the highest 
biological activity [5,16,17]; therefore, 
transformation of the SC to other isoforms like 
open circular (OC) or linear is considered as 
degradation. In this study, surfactants that 
function as emulsifiers have been evaluated for 
the potential use as pDNA protective agents. The 
mechanism of SC pDNA preservation by non-
ionic surfactants during microsphere fabrication 
has never been investigated before. Previous 
studies showed that the presence of the polymer 
(PLGA) in the oil phase was the main inducer for 
pDNA degradation upon the exposure to the 
shear force [9,18]. It was proposed that the 
hydrophobic vinyl acetate part of the partially 
hydrolysed PVA acted as anchors at the DCM 
interface. Once it is entangled with PLGA, it 
becomes very difficult to be removed from the 
surface [19,20]. These entanglements could trap 
the pDNA leading to conformational change in 
the pDNA due to the shear stress [9]. We 
postulate that the non-ionic surfactant added to 
the pDNA in W1 may have been adsorbed on the 
DNA strands by means of hydrogen bonding and 
other forces, hence making a protective 
‘envelope’ around the pDNA. The envelope acts 
as a shield against the shear stress caused by 
PLGA and PVA molecules. This could be 
predicted especially for formulations containing 
Tween and TX whereby both surfactants have 
long hydrophilic polyoxyethylene side chains. 
This favourable interaction could be similar to the 
interaction between polyethylene glycol (PEG) 
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and DNA, which results in precipitating of DNA 
molecules [21]. Microspheres prepared with 
Span alone (F2) did not show similar 
preservation efficiency. This could be due to the 
absence of a long hydrophilic chain to interact 
with the pDNA. Furthermore, Span seems to 
compromise the preservation efficiency of Tween 
but not TX. This could be explained by looking at 
the plasticising effect of these surfactants on 
PLGA, i.e. by comparing their Tg. Lower Tg 
implies plasticising effect and indicates disruption 
of the polymer molecular arrangement. PVA was 
present in all formulations and accounted for the 
increased Tg of all microspheres (Tg of ‘raw’ 
PLGA is 38.3 °C), indicating anti-plasticising 
effect. Consequently, when a surfactant results in 
Tg lower than that of PVA-containing 
microsphere (F1), this surfactant acts as 
stabiliser hence it compromises the interaction 
between PVA and PLGA. When Span and 
Tween were blended (F3-5, Table 1), the 
plasticising effect of the blend was lower than 
that when Span only (F2) or Tween only (F6) 
was used. On the other hand, blending Span with 
TX enhanced the plasticising effect of each of 
them (F10 compared to F7). This may be 
attributed to the tendency of Span and Tween 
molecules to enter in some kind of molecular 
association at the oil-water interface [22], hence 
reducing the amount of the surfactants in the 
PLGA matrix. It was reported that the emulsifier 
molecules cannot associate easily when the 
hydrocarbon chains contain less than 8 carbon 
atoms [22], the character that is not available in 
TX molecule (Fig. 1). Consequently, Span-TX 
blend exhibited better preservation efficiency 
than Span-Tween blends. By providing a 
protective envelope around DNA strands and 
compromising the PLGA and PVA molecular 
interactions, the non-ionic surfactants seems to 
act as lubricants that protect the labile pDNA 
from the shear force caused by PLGA and the 
entangled PVA molecules. 
 
Even though the postulated mechanism seems 
to suggest that PVA is detrimental to the integrity 
of the pDNA, high SC preservation was observed 
in F1 when PVA was employed as a surfactant 
for W/O emulsion. It seems that PVA imparted its 
protective effect when it was added to the W1 
phase in the primary emulsion.   
 
The release of encapsulated substance from 
PLGA microspheres is governed by diffusion of 
the substance and degradation of the PLGA [23]. 
Different surfactants revealed apparently 
different release profiles. This can be partially 
attributed to the difference in hydrophobicity of 
the microspheres due to the different surfactant 
blends. The hydration of the particles was 
strongly influenced by the hydrophilicity of the 
surfactants, which enhances the degradation rate 
of the particles leading to faster release [2]. F4, 
which was relatively more hydrophobic than F6 
and also had larger particle size, exhibited faster 
release with a very high burst release. SEM 
image of F4 displayed total collapse of the PLGA 
wall by 4th weeks of incubation. Additionally, the 
reverse micelle formation due to the presence of 
Span in F4 could attribute to the fast release of 
pDNA. The pDNA could be trapped in the 
reverse micelles, which become microchannels 
upon contact with water. This particular 
localisation together with the weak interaction 
between the hydrophilic pDNA and the 
hydrophobic PLGA resulted in the observed high 
burst release from F4. In contrast, F7 that 
contains TX seems to be very stable 
morphologically throughout the release period. 
The surfactants exhibited strong effect on the 
burst release (Fig. 3 A). However, after the burst 
release the three formulations exhibited release 
profile fitted properly on Higuchi model (Fig. 3 B) 
suggesting a diffusion controlled release 
mechanism in the sustained release phase [24].  
 
Only the pDNA from F4 was detected on agarose 
gel in the first week. This can be attributed to the 
high burst release from F4. Since pDNA was 
successfully extracted from the remaining 
microspheres of F7 (lane 6 in Fig. 5), the 
absence of the released pDNA from F7 in 
agarose gel may be related to the slow release 
profile as shown previously in Fig. 3 A. The 
pDNA seems to be stable after 4-weeks release 
period from the microspheres modified with 
different surfactants. In addition, the incorporated 
surfactants did not show significant cytotoxicity 
even though some of them such as TX is known 
to be highly toxic. In fact, TX is used in cell lysis 
buffers [25].  
 
CONCLUSION 
 
The findings of this study reveal the essential 
roles of surfactants not only as emulsifiers but 
also as protective agents to obtain sufficient 
supercoil pDNA from encapsulated PLGA 
microspheres. Supercoil index (SCI), as a 
harmonised value between encapsulation 
efficiency and supercoil preservation efficiency, 
is a useful indicator of the quality of 
microspheres. Among surfactants, the Tween 
blend of HLB 16 resulted in the highest SCI. The 
results also indicate that these surfactants can 
be used to protect pDNA and to modulate its 
Doolaanea et al 
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release from PLGA microspheres without 
compromising the biocompatibility of the 
microspheres. 
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